Key Financials | KlickAnalytics

41.87 -0.75(-1.75%)05/17/2024
Ultragenyx Pharmaceutical Inc. (RARE)

(Values in USD Thousands)

	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Net Income	-170,684	-159,649	-159,828	-163,972
Revenue	108,833	98,052	108,309	100,496
Cost Of Revenue	26,378	10,987	9,914	12,257
gross Profit	82,455	87,065	98,395	88,239
Operating Expenses	247,802	232,162	246,352	242,344
Selling General and Administrative Expenses	78,160	74,917	81,403	76,646
Research and Development Expenses	169,642	157,245	164,949	165,698
Other Expenses	-1,605	5,182	-1,989	6,598
Cost And Expenses	274,180	243,149	256,266	254,601
Operating Income	-165,347	-145,097	-147,957	-154,105
Interest Income	8,824	5,881	5,964	6,290
Income Tax Expense	455	650	732	495
Income Before Tax	-170,229	-158,999	-159,096	-163,477
Earning Per Share Basic	-2.03	-2.23	-2.25	-2.33
Earning Per Share Diluted	-2.03	-2.23	-2.25	-2.33
weighted Average Shares Outstanding	84,286	71,664	70,898	70,368
weighted Average Shares Outstanding (Diluted)	84,286	71,664	70,898	70,368
Gross Margin	0.76	0.89	0.91	0.88
EBIT Margin	-1.44	-1.43	-1.28	-1.47
Profit Margin	-1.57	-1.63	-1.48	-1.63
EBITDA	-156,502	-139,915	-138,621	-147,507
Earning Before Tax Margin	-1.56	-1.62	-1.47	-1.63